EUVIMEDEUVIMED entdecken
Crossref

Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy

Baoyuan Li, Fengying Cui, Jingyuan Suo, Xiangjun Chen iD, Jinrong Peng iD, Wei Hong iD, Wenting Li iD

ACS Applied Materials & Interfaces · 29.04.2026 · 18 (16) · 22944-22960

DOI: 10.1021/acsami.6c02486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 15.04.2026. Verfasst von Baoyuan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao University, Yantai Yuhuangding Hospital, Department of Otolaryngology Head & Neck Surgery, Yantai 264000, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Photosensitizing Agents, X-Box Binding Protein 1, Silicon Dioxide. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Key Research and Development Program of Sichuan Province, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesPhotosensitizing AgentsX-Box Binding Protein 1Silicon DioxideImmunotherapyAnimalsMiceFemaleGlutathioneCell Line, TumorHumansMice, Inbred BALB CEndoplasmic Reticulum Stressbeta-Cyclodextrins

Stichwörter der Autor:innen

Antitumor combination therapyEndoplasmic reticulum stressMitochondrial dysfunctionPhotoimmunotherapyTargeting codelivery

Substanzen

Photosensitizing AgentsX-Box Binding Protein 1Silicon DioxideGlutathioneXbp1 protein, mousebeta-Cyclodextrins

Autor:innen und Institutionen

  • Qingdao University, Yantai Yuhuangding Hospital, Department of Otolaryngology Head & Neck Surgery, Yantai 264000, P. R. China.
  • School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai 264003, P. R. China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan 610041, P. R. China.

ORCID-Profile: Xiangjun Chen, Jinrong Peng, Wei Hong, Wenting Li

Förderung

  • Natural Science Foundation of Shandong Province
  • Key Research and Development Program of Sichuan Province
  • National Natural Science Foundation of China (NSFC)
  • Provincial-Level Leading Talent Sponsorship Program by Yantai

Zitieren

APA

Li, B., Cui, F., Suo, J., Chen, X., Peng, J., Hong, W., & Li, W. (2026). Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy. ACS Applied Materials & Interfaces, 18(16), 22944-22960. https://doi.org/10.1021/acsami.6c02486

Vancouver

Li B, Cui F, Suo J, Chen X, Peng J, Hong W, et al. Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy. ACS Applied Materials & Interfaces. 2026;18(16):22944-22960. doi:10.1021/acsami.6c02486

BibTeX
@article{Li2026,
  author = {Li, Baoyuan and Cui, Fengying and Suo, Jingyuan and Chen, Xiangjun and Peng, Jinrong and Hong, Wei and Li, Wenting},
  title = {Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {16},
  pages = {22944--22960},
  doi = {10.1021/acsami.6c02486}
}
Kostenlos starten →